| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH |
From the Departments of Obstetrics and Gynecology, and the Probability, Statistics, and Information, University of Washington, Seattle, Washington.
Address reprint requests to: Thomas R. Easterling, MD Department of Obstetrics and Gynecology Box 356460, University of Washington 1959 Pacific Street, NE Seattle, WA 98195 E-mail: easter{at}u.washington.edu
Objective: To determine if assessment of maternal hemodynamics could predict women at risk for the development of preeclampsia, if treatment directed at hemodynamic abnormalities before the onset of hypertension could prevent preeclampsia, and if mothers could be treated in a way that protects fetal growth.
Methods: A double-blinded, randomized controlled trial was conducted. Subjects were considered to be at risk for preeclampsia if their cardiac output was greater than 7.4 L/min before 24 weeks’ gestation. Nulliparous and diabetic subjects at risk were treated with 100 mg of atenolol or placebo. Cardiac output was measured by Doppler technique. Inulin and para-aminohippurate clearances were performed.
Results: Treatment with atenolol reduced the incidence of preeclampsia from 5 of 28 (18%) to 1 of 28 (3.8%), (P = .04). Nulliparous women determined to be at risk for preeclampsia were similar to diabetic women at risk. Each was significantly heavier and had inulin and para-aminohippurate clearances greater than the control group. Treatment with atenolol was associated with infants weighing 440 g less than infants in the nulliparous placebo group, (P = .02). No effect on birth weight was seen in the diabetic patients. Mothers of the smallest infants who were treated with atenolol could be identified by unexpectedly large reductions in cardiac output.
Conclusion: Measurement of cardiac output in the second trimester identified women at risk for preeclampsia. Treatment with atenolol decreased the incidence of preeclampsia. Nulliparous and diabetic women at risk for preeclampsia were similar with regard to maternal hemodynamics, maternal weight, and renal function. Treatment with atenolol was associated with reduced infant birth weight.
This article has been cited by other articles:
|
|
 |
|
  M. Hladunewich, S. A. Karumanchi, and R. Lafayette Pathophysiology of the Clinical Manifestations of Preeclampsia Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 543 - 549. [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Hebert, D. B. Carr, G. D. Anderson, D. Blough, G. E. Green, D. A. Brateng, E. Kantor, T. J. Benedetti, and T. R. Easterling Pharmacokinetics and Pharmacodynamics of Atenolol During Pregnancy and Postpartum J. Clin. Pharmacol., January 1, 2005; 45(1): 25 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J Steer, M. P Little, T. Kold-Jensen, J. Chapple, and P. Elliott Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study BMJ, December 4, 2004; 329(7478): 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Bryson, G. N. Ioannou, S. J. Rulyak, and C. Critchlow Association between Gestational Diabetes and Pregnancy-induced Hypertension Am. J. Epidemiol., December 15, 2003; 158(12): 1148 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Kametas, F. McAuliffe, E. Krampl, J. Chambers, and K. H. Nicolaides Maternal Cardiac Function in Twin Pregnancy Obstet. Gynecol., October 1, 2003; 102(4): 806 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Damron and B. M. Sibai Chronic Hypertension In Pregnancy Obstet. Gynecol., December 1, 2002; 100(6): 1358 - 1359. [Full Text] [PDF]
|
|
|
|
|
|
B. M. Sibai Chronic Hypertension in Pregnancy Obstet. Gynecol., August 1, 2002; 100(2): 369 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Reis, D. D'Antona, and F. Petraglia Predictive Value of Hormone Measurements in Maternal and Fetal Complications of Pregnancy Endocr. Rev., April 1, 2002; 23(2): 230 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Carr, G. B. McDonald, D. Brateng, M. Desai, C. T. Thach, and T. R. Easterling The Relationship Between Hemodynamics and Inflammatory Activation in Women at Risk for Preeclampsia Obstet. Gynecol., December 1, 2001; 98(6): 1109 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Easterling, D. B. Carr, D. Brateng, C. Diederichs, and B. Schmucker Treatment of Hypertension in Pregnancy: Effect of Atenolol on Maternal Disease, Preterm Delivery, and Fetal Growth Obstet. Gynecol., September 1, 2001; 98(3): 427 - 433. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
